The Life Sciences Industrial Strategy, supported by Government and led by Sir John Bell, has been launched today in Birmingham.
Parliamentary Under-Secretary of State at the Department for Business, Energy and Industrial Strategy, Lord Prior of Brampton, has today visited AstraZeneca’s Macclesfield Pharmaceutical Manufacturing Facility.
Following new Fraser of Allander Institute (FAI) analysis that maps out the economic contribution of Scotland’s pharmaceutical sector, the new Director of ABPI Scotland has called upon the Scottish Government to continue to support and prioritise strategic investments in Scotland’s research,...
The Department of Health has today [6 July] published the Q1 2017 PPRS data showing that the pharmaceutical industry has paid £94 million during the first quarter (Q1) of 2017 under the 2014 Pharmaceutical Price Regulation Scheme (PPRS).
A new report published today shows that the UK is trailing behind the rest of Europe in the treatment of cancer. British patients have worse survival rates after five years - the international benchmark for measuring the quality of cancer care – compared to the European average in nine out of ten...
Following the publication of ‘Pharmaceutical companies’ policies on access to trial data, results, and methods: audit study’, the Association of the British Pharmaceutical Industry has issued the following statement.
Last week, the EMA announced it has completed the reallocation of the medicines for which the UK's national regulator - the MHRA - is currently rapporteur or co-rapporteur appointed by the scientific committees to coordinate the evaluation of a medicine.
Life Science leaders from across the UK have welcomed a new agreement that will make it easier for life-changing medicines and vaccines research and development to take place across different parts of the UK.
This morning, The Times published an investigation into the transfers of value received by healthcare professionals (HCPs) and healthcare organisations (HCOs) across Europe from the pharmaceutical industry.
Responding to a new House of Commons Health and Social Care Select Committee report ‘Brexit – Medicines, Medical Devices and Substances of Human Origin’, the trade associations representing the UK's pharmaceutical and biotech industries have issued a joint response backing the Committee's...